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Over hundred new a priori global/local molecular descriptors that encoded steric, topological,
electronic, hydrogen bonding, compositional and hydrophobic properties were generated for 16
b-lactams, and two partial least squares regression models were constructed and cross-vali-
dated. These a priori models (Q2 > 0.80, R2 > 0.95, SEV < 0.50) are comparable with the pre-
viously obtained computed models. b-Lactam intramolecular and b-lactam-receptor intermole-















Quantitative Structure-Activity Relationships (QSAR),1–3
Quantitative Structure-Property Relationships (QSPR)4,5
and Linear Free Energy Relationships (LFER)6,7 are quan-
titative relationships between a dependent variable and
independent variables called molecular descriptors. Rep-
resentations of molecules are sources of information for
generation of the descriptors at different structural levels:
1D (chemical composition), 2D (chemical formula), 3D
(atomic coordinates) or higher structural levels8,9 such as
those in ND-QSARs.10,11
A simple approach for chemical interpretation of
descriptors is the a priori approach with a priori descrip-
tors, as postulated by present authors a few years ago.8,11
A priori descriptors are known-before-computer-assistance
since they can be easily made, by employing 1D or 2D
chemical formula, chemical knowledge and a minimum
amount of literature data. The a priori approach does not
mean using several tabulated descriptors (as in the Hansch-
-Fujita approach12), codes for molecular fragments (as in
Free-Wilson approach13) or exclusively topological de-
scriptors. The emphasis of the a priori approach is on in-
tuitive generation of molecular descriptors.
A priori molecular descriptors have been successfully
applied to QSAR of HIV-1 protease inhibitors8,11 with PLS
(Partial Least Squares)1 regression, and have been com-
bined with computed descriptors in QSAR studies of b-
-lactam antibiotics14 and progestogens.3,15 A priori che-
mical bond descriptors have been used in PLS studies of
planar benzenoid hydrocarbons16 and nucleobases.17 En-
couraged by these results, we present a new application
of the a priori approach to 16 b-lactam antibiotics (Fig-
ure 1) and correlate a priori molecular descriptors with
biological activities by establishing PLS models compa-
rable to earlier results.14 The emphasis of this work is in
extending the a priori approach to microbial resistance
phenomena and to represent the advantages of this ap-
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proach (especially in terms of model interpretability)
while not necessarily obtaining QSAR models better than
in the literature. Exploratory analysis of a priori data by
means of Principal Component Analysis (PCA)1 and Hi-
erarchical Cluster Analysis (HCA)1 is performed to give
more insight into the chemical background of the de-
scriptors. Biological activities are Minimal Inhibitory Con-
centration (MIC) values18 for b-lactams that are extru-
ded from Gram-negative bacterial cells by means of a
three-component multidrug resistance efflux pump
AcrAB-TolC19–21(Figure 2). Efflux pumps22–25 are one of
the most important Multidrug Resistance (MDR)26,27 in-
trinsic mechanisms in all cellular microbes and cancer
cells as effective defense systems against a large variety
of drugs and other structurally non-related xenobiotics.
Recent studies on bacterial MDR efflux pumps22–25,28–31
and crystal structures of AcrB,32–36 AcrA37 and TolC38,39
point out non-specific interactions between drugs and
AcrAB-TolC as a good example for drug-pump interac-
tions in bacteria. b-Lactam molecules in bacterial peri-
plasm or cytoplasm interact with the inner membrane or
AcrB pump and are transferred to the openings called ve-
stibules. AcrAB-TolC is trimeric (the dimer is shown in
Figure 2 for clarity), where the cylinder-like TolC is
docked to the jelly-fish shaped AcrB, and AcrA addi-
tionally connects AcrB and TolC together and with the
membranes. AcrB has three vestibules with characteristic
BRAMLA shape (BRAzil Map-Like Area14,40) that meet
in the central cavity where drug molecules are collected.
The nearest cellular ATP hydrolysis causes proton influx
that provokes conformational changes in the pump and
its components like the opening of the AcrB-TolC chan-
nel through which the drugs are excreted. Drug molecu-
lar properties are important for drug interaction with this
efflux system.
Penicillins and cephalosporins are the most impor-
tant b-lactam antibiotics.41 Physico-chemical42–45 and
theoretical14,46,47 studies have pointed out the amphiphi-
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Figure 1. Structures of b-lactams at neutral pH, with atomic numbering for penicillins and cephalosporins.
lic character of these compounds and the majority of an-
tibiotics, due to which all of them behave as classical de-
tergents or surfactants. This includes drug concentration
at the hydrophobic-hydrophilic interface, self-association,
interaction with biomembranes and proteins,42 penetra-
tion through cellular membranes and intestinal absorption.
Most drugs, wheather natural or synthetic, are amphiphi-
lic,42 as are amino-acids and proteins,48,49 because of
which protein folding and protein interactions with di-
verse kinds of molecules occur. AcrAB-TolC belongs to
the Resistance Nodulation Division (RND)22–25 family of
transporters whose substrates are rather amphiphilic.
However, protein-drug interactions are rarely described
in QSAR by drug amphiphilic descriptors.49 In this work,
the nature of b-lactam descriptors including amphiphili-
city, is highlighted.
METHODS
MICs were determined as mass concentrations for mole-
cular and ion/zwitterion species (Figure 1) by Nikaido et
al.18 at neutral pH, as excreted by strains SH5014 (par-
ent strain) and HN891 (AcrAB overproducer) of patho-
gen bacteria Salmonella typhimurium. pMICs are defi-
ned as pMIC = –log [MIC/(mol dm–3)]. Molecular de-
scriptors were generated employing chemical composi-
tions and structural formulae of b-lactams (Figure 1) and
some atomic constants. A few descriptors were from the
previous study.14
Descriptors and biological activities were auto-
scaled, i.e., reduced by the respective mean values and
then divided by the respective variances, prior to every
chemometric analysis due to differences in their orders
of magnitude. Three types of chemometric methods1 were
employed in this work: Principal Component Analysis
(PCA), Hierarchical Cluster Analysis (HCA) and Partial
Least Squares (PLS) regression. PCA is a data compres-
sion method, in which original molecular descriptors with
usually substantial intercorrelations are linearly combined
into principal components (PCs) which are mutually or-
thogonal. The PCs are arranged in decreasing order of
the total variance contents, so that only a few PCs are
sufficient to visualize and explain the original data. A
preprocessed data matrix X(I´J) for n molecules and m
descriptors is decomposed into two matrices T and L such
that X = TLT, where T is the scores matrix, representing
positions of compounds in the new coordinate system. L
is the loadings matrix, i.e., the transformation matrix con-
necting original descriptors and PCs. HCA is another,
two-dimensional way to present the original data in form
of the dendograms. Euclidean distances dij between com-
pounds i and j are calculated using elements of X, result-
ing in the similarity matrix S. The same procedure can
be applied to descriptors. Elements of S are similarity indi-
ces defined as Sij = 1 – dij/dmax, where dmax is the largest
distance between any pair of compounds or descriptors.
In PLS regression, the matrix X of molecular
descriptors is correlated with the vector y of biological
activities. The regression equation y = Xb is solved by
maximizing the variance between y and T, which results
in k principal components (latent variables). The PLS re-
gression model is built by using k essential principal
components. The model is internally validated by leave-
-one-out crossvalidation, in which every compound is
predicted from a regression that was built without using
the data for this compound. The following statistical pa-
rameters are important to access the goodness of a PLS
model:
a) standard error of calibration SEC = [Si (yei – yci)
2/
(n – k –1)]1/2,
b) standard error of leave-one-out crossvalidation SEV
= [Si (yei – yvi)
2/n]1/2,
c) correlation coefficient of calibration
R2 = 1 – [Si (yei – yci)
2]/ [Si (yei – <yei>)
2],
d) correlation coefficient of leave-one–out crossvalida-
tion Q2 = 1 – [Si (yei – yvi)
2]/ [Si (yei – <yei>)
2],
e) linear correlation coefficient of calibration
R = [Si (yei – <yei>)(yci – <yci>)] /
[Si (yei – <yei>)
2]1/2 [Si (ypi – <ypi>)
2]1/2,
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Figure 2. AcrAB-TolC efflux pump. TolC is docked to AcrB. Only
one vestibule is visible in this orientation, while the other two are
placed in the back side of the AcrB trimer, at the joint lines of the
monomers. Arrows show the substrate efflux pathway starting from
the periplasm and cytoplasm.
f) linear correlation coefficient of leave-one-out cross-
validation
Q = [Si (yei – <yei>)(yvi – <yvi>)] /
[Si (yei – <yei>)
2]1/2 [Si (yvi – <yvi>)
2]1/2
where:
i is the summation index; ye are experimental values of
y; yc and yv are values of y obtained from calibration and
crossvalidation, respectively; and <ye>, <yp> and <yv>
are mean values of ye, yp and yv, respectively. It is impor-
tant to note that squares (R)2 and (Q)2 of linear correla-
tion coefficients R and Q, although numerically close, are
not equal to correlation coefficients R2 and Q2.
Variable selection for the PLS model for strain
HN891 was started by an initial cut-off in linear correla-
tion coefficients for descriptor-activity correlations (ab-
solute values < 0.600). The second part of variable se-
lection consisted of systematic manual variable elimina-
tion, a procedure that was aided by the following items:
a) Descriptors with pronounced dispersion and non-uni-
form distribution of data (for example, chance correla-
tions and false non-linearity) in descriptor-activity corre-
lograms were eliminated; b) Descriptors from the same
clusters in HCA dendograms and PCA loadings plot were
eliminated as much as possible; c) Descriptors with small
contribution to the PLS regression vector were elimina-
ted; d) Descriptors whose presence resulted in worsened
PLS statistics than when excluded from the model were
also eliminated; e) Descriptors of the same type (like ste-
ric, topological, electronic, hydrogen bonding, composi-
tional and combined) were eliminated as much as possi-
ble; f) Descriptors generated in the same way were elim-
inated as much as possible; g) Descriptors that were com-
plex to obtain and interpret were eliminated as much as
possible. pMIC(HN891) and pMIC(SH5014) are highly
correlated (linear correlation coefficient is 0.980),14 which
justified the use of the same descriptors in the two final
PLS models. External validation was performed by ex-
cluding b-lactams 7, 10 and 14, which represent broad
activity ranges and behave differently in exploratory ana-
lyses from previous work.14
Exploratory analysis (PCA and HCA with incremen-
tal linkage) related to strain HN891 was performed us-
ing the same set of descriptors (data set A). Two sets of
descriptors, with moderate to high values of absolute cor-
relation coefficients (> 0.600) with the two pMICs were
used in an additional PCA analysis (data set B related to
HN891 activities, and data set C related to SH5014 acti-
vities). All chemometric analyses were performed by us-
ing programs Matlab 5.250 and Pirouette 3.02.51
RESULTS AND DISCUSSION
Molecular Descriptors
Application of the a priori approach to the set of 16
b-lactams (Figure 1) resulted in 105 new molecular
descriptors, which, together with 21 descriptors from the
earlier study,14 formed the complete data set. Table I
contains descriptors that have absolute correlation coef-
ficients with one or both pMICs (for HN891 and SH5014
strains) above 0.600. Compositional (CM), steric (ST),
electronic (EL), hydrogen bonding (HB), topological (TP),
hydrophobic (HP) and complex descriptors were gener-
ated by considering mainly atoms, bonds, electrons and
other structural units, and sometimes from the literature
(Pauling atomic electronegativities) and chemical know-
ledge (fragment characteristics based on well-known ato-
mic, group or element properties). Descriptors were gen-
erated for b-lactam molecules/ions (global descriptors) and
their side chains (local descriptors). Some were made as
a function of one or more local or global descriptors: Gaus-
sian transforms, sums, differences, ratios and functions
normalized by the number of structural units (atoms,
bonds, etc.), among others. All topological descriptors
were counted as Wiener or Randi} indices of the zeroth
or first order,31 their transforms or rational functions.
It is important to comment about the definition of
molecular fragments. The central molecular fragment was
considered as a fragment with no or little structural vari-
ation: the b-lactam ring and small exocyclic groups (car-
boxy, carbonyl and methoxy in 5, 10 and 13). Therefore,
side chains (two variable fragments) are as defined in
Figure 1: the left fragment always contains substituent R,
and the right fragment includes R1 in cephalosporins and
its analogue C2-Me2 in penicillins. The left fragment, de-
pending on descriptor definitions (Table I), includes only
R, R-CO-N8 (penicillins) or R-CO-N9 (cephalosporins),
R-CO-N8-C6 (penicillins) or R-CO-N9-C8 (cephalospo-
rins). The right fragment in cephalosporins is defined most
frequently as C3-R1, and sometimes as R1. For calcula-
tion of Wiener and Randi} indices of the zeroth order,
the variable fragments included chemical bonds with the
central fragment: N8-C6 (penicillins) or N9-C8 (cephalo-
sporins) for the left fragment, and C2-S1 and C2-C3 (pe-
nicillins) or C2-C3 and C3-C4 (cephalosporins). Figures
3–5 illustrate generation of the most important molecu-
lar descriptors for a good (2) and bad (12) substrate of
the MDR pump AcrAB-TolC. Nar1 can be obtained as the
number of non-H atoms in the right fragment CR1/CMe2
as defined in Figure 3a (3 for 2 and 12 for 12). 2 and 12
are in anionic and dianionic forms at neutral pH, respec-
tively. From their respective formulas [C19H17ClN3O5S]
–
and [C18H16N8O7S3]
2– 29 and 52 atoms, and 152 and 190
valence electrons are counted. This gives 3.30 and 3.65
valence electrons per atom (Vav). Figure 3b shows hydro-
gen bond (HB) donor and acceptor atoms in 2 and 12.
Counting these atoms (NDA) and dividing them by the to-
tal number of non-hydrogen (non-H) atoms in the anions,
one gets the number fraction of HB donors and accep-
tors wDA: 7/29 = 0.241 for 2 and 14/36 = 0.389 for 12.
Figure 3c illustrates the definition of the valence elec-
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tron contents of non-H atoms in the side chains, relative
to carbon (Z). Anionic/cationic charges are ignored and,
therefore, one counts these numbers of valence electrons
and atoms: a) for 2: 58 electrons and 13 atoms from the
left fragment, and 12 electrons and 3 atoms from the right
fragment; b) for 12: 47 electrons and 10 atoms from the
left fragment, and 53 electrons and 11 atoms from the right
fragment. Finally, simple calculation gives Z = v(R) +
v(R1’) – 8 = 58/13 + 12/3 – 8 = 0.462 for 2 and Z =
47/10 + 53/11 – 8 = 1.518 for 12. Descriptor L, the num-
ber of non-H atoms along the longest chain in a mole-
cule, includes 4 atoms of six- or five-membered rings in
the side chains, as defined in Figure 3d. L is equal to 13
for 2, and to 20 for 12. The number of non-H atoms,
when divided by the number of domains of distinct hy- drophobic/hydrophilic character (illustrated in Figures
4a and 4b), gives the average size of domains Dav, being
equal to 29/6 = 4.8 for 2 and 36/13 = 20 for 12. Wsd is
calculated from the number of non-H atoms and the first
order Wiener index for the extended left and right chains
(W, Nr and W1, Nr1, respectively), as defined in Figure
5a. Calculation of the Wiener index for the right fragment
of 12 is shown in Figure 5b, with arbitrarily numbered
atoms and the topological distance matrix (matrix with
diagonal symmetry), partial sums and the total sum W1.
Final calculations give Wsd = [W/(Nr)
3 – W1/(Nr1)
3]2 =
[492/173 – 4/33]2 = 0.002304 for 2 and Wsd = [306/143 –
196/123]2 = 0.000004 for 12.
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2 ( = 7)NDA 12 ( = 14)NDA
2 ( = 3)Nar1 12 ( = 12)Nar1
Figure 3. Definition and calculation of some molecular descrip-
tors for 2 and 12: a) number of non-hydrogen atoms in the right
fragment CR1/CMe2 (Nar1); b) number of hydrogen bond donors
and acceptors (NDA); c) electron contents of the left (v(R)) and right
(v(R1)) fragments without hydrogen atoms; d) number of non-hy-
drogen atoms along the path from the R1 end to the R end (L).
Hydrogen bond donors and acceptors are marked bold and with
lone pairs colored black.
2 (6 domains) 12 (13 domains)
a) b)
Figure 4. The number and distribution of hydrophobic (gray tones)
and polar (white ellipses) domains in a) 2 and b) 12. Domain
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Figure 5. Definition and calculation of the topological descriptor
Wsd. a) Definition of the left and right fragments for the first order
Wiener index. b) Calculation of W1 and normalized W1n for the
right fragment of 12, with arbitrary numbering of non-hydrogen
atoms.
PLS Models
Seven molecular descriptors (bold in Table I) were se-
lected for PLS models to predict pMIC(HN891) and
pMIC(SH5014). Selected data are in Table II. The two a
priori models (Table III) have the same number of b-lac-
tams and descriptors and similar statistics as analogous
computed models from the earlier work.14 The computed
models used only three a priori descriptors, a quantum-
-chemical descriptor and three lipophilic descriptors.
External validation results for the a priori PLS mod-
els are in Table III. The two PLS models are similar due
to high correlation between pMIC(HN891) and pMIC
(SH5014). According to their basic statistics (Q2 > 0.81,
R2 > 0.95, SEV < 0.50, 4 PCs), acceptable relative errors
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TABLE I. Molecular descriptors used in exploratory analyses and PLS models
No.(a) Symbol(b) Definition Nature(c) HN891(d) SH5014(d)
6 Nar1 number of non-H atoms in CR1/CMe2 fragment CM/ST/HP 0.647 0.558
8 Nbr1 number of bonds in CR1/CMe2 (H-atoms excluded) ST 0.614 0.523
9 Nsrr1 function Nar+Nar1; Nar is the number of non-H atoms in RCON ST –0.693 –0.600
10 Nqrr1 function Nar/Nar1 ST –0.744 –0.655
11 Bsrr1 function Nbr+Nbr1; Nbr and Nbr1 are numbers of non-H atoms in
CR1/CMe2 and RCON fragments, respectively
ST –0.678 –0.596
12 Bqrr1 function Nbr/Nbr1 ST –0.755 –0.675
15 wC
(*) number fraction of hydrophobic carbon atoms (all C atoms except those
in C=O, C-O- and CN groups)
CM/HP –0.764 –0.739
21 Pav average Pauling atomic electronegativity EL 0.745 0.752
23 Pr average Pauling atomic electronegativity of RCON EL 0.703 0.703
24 Prav function (Pr+Pr1)/2; Pr1 is average Pauling electronegativity of CR1/CMe2 EL 0.743 0.744
26 Prp function Pr*Pr1 EL 0.747 0.748
29 Npol number of polar non-H atoms (C from C=O, C-O
–, CN; S from SO3; Cl;
N)
CM/EL/HB 0.723 0.674
30 K ratio of numbers of hydrophobic and polar atoms CM/HB/HP –0.693 –0.676
31 whyd number fraction of non-H hydrophobic atoms CM/HP –0.696 –0.667
32 wh2 number fraction of hydrophobic atoms: amphiphilic atoms are O, Cl and
S in C-Cl, C-O-C and C-S-C bonds: each such atom is added to
hydrophilic C atoms counted for wC
CM/HP –0.737 –0.704
33 Npol2 number of polar atoms expressed as (1–wh2)Nnh; Nnh is the number
of non-H atoms
HB/HP/EL 0.742 0.690
34 D number of hydrophobic and polar domains HB/HP/EL 0.727 0.680
35 Dav average size of domains counted for D, NnH/D ST/HP –0.783 –0.738
36 Nrb-tr function (Nrb–5)
2; Nrb is the number of rigid bonds in R, including
double, aromatic and delocalized bonds
ST/HP/EL –0.556 –0.609
39 Vav number of valence electrons per atom EL 0.656 0.676
41 NHB
(*) number of hydrogen bonds, (number of HB donors+acceptors) HB 0.619 0.561
42 Nhba
(*) number of hydrogen bond acceptor bonds (number of H bonds originated
from HB acceptors = number of lone pairs in N atoms + in carbonyl,
oxide, sulfonate and hydroxyl O atoms)
HB 0.638 0.596
44 NDA
(*) number of heteroatoms which are HB donors/acceptors HB/EL 0.727 0.682
45 wDA(*) number fraction of HB donors and acceptors HB 0.686 0.657
46 Z(*) function v(R)+v(R1’)–8; v(R), v(R1’) are average numbers of valence




(*) number of non-s valence electrons (p-electrons and lone pair electrons;
sulfur in b-lactam ring is excluded)
EL/HP/HB 0.628 0.596
48 whet
(*) number fraction of heteroatoms CM/EL/HB 0.772 0.751
49 Nhet
(*) number of heteroatoms (all N, O, S, Cl) CM/EL 0.749 0.710
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50 R1 average number of valence electrons in substituent CR1/CMe2 EL 0.666 0.651
52 NNS
(*) number of N and S atoms (except S in sulfonate groups) CM/EL/HB 0.713 0.680
53 NN* number of nitrogen atoms CM/EL/HB 0.710 0.670
54 wN number fraction of nitrogen atoms CM/EL/HB 0.677 0.650
55 wNS number fraction of N and S atoms CM/EL/HB 0.663 0.629
58 L number of non-H atoms in the shortest path from the R end to
the R1 end
CM/ST/HP 0.695 0.601
59 wL number fraction of non-H atoms counted for L CM/ST/HP 0.621 0.532
61 Lav-tr function exp[–(Lav–2.10)
2]; Lav is average number of domains
counted for D along chain defined by L
HB/HP/EL –0.620 –0.630
62 D2 number of domains along chain defined by L; small side chains
along the chain are excluded
HB/HP/EL 0.681 0.585
78 Nr1 number of non-H atoms in CR1/CMe2 CM/ST 0.647 0.558
79 Drr1 function Nr-Nr1; Nr is the number of non-H atoms in RCONC CM/ST –0.675 –0.598
80 Qrr1 function Nr/Nr1 CM/ST –0.734 –0.656
83 Wsd function (Wn–Wn1)2; Wn=W/(Nr)3, Wn1=W1/(Nr1)3; W, W1 is the first
order Wiener index for RCONC and C3R1/C3Me2 extended fragment,
respectively
TP –0.774 –0.713
84 Qwrr1 function W/W1 TP –0.768 –0.705
88 Q2wrr1 function Wno/Wno1; Wno= W/(Nr)
2; Wno1= W1/(Nr1)
2 TP –0.655 –0.584
93 Vr1 zeroth-order extended Wiener index for CR1/CMe2 TP 0.639 0.548
94 Kr1 zeroth-order Randi} index for CR1/CMe2 TP 0.644 0.559
96 Kr1av Kr1 averaged per atom in the fragment TP –0.642 –0.548
97 Vd function Vr–Vr1; Vr is zeroth-order Wiener index for RCON TP –0.697 –0.613
98 Vq function Vr/Vr1 TP –0.753 –0.672
99 Kd function Kr–Kr1 TP –0.642 –0.576
100 Kq function Kr/Kr1 TP –0.710 –0.638
101 Kavd function Krav–Kr1av; Krav, Kr1av is Kr and Kr1 averaged per atom in
the fragment, respectively
TP 0.710 0.594
102 Kavq function Krav/Kr1av TP 0.697 0.580
110 Cr1 first order Randi} index for CR1/CMe2- TP 0.649 0.557
111 Cr1av Cr1 per number of bonds in the fragment TP 0.640 0.573
112 Er1av Er1 per number of bonds; Er1 is the 126
th descriptor in this table TP –0.643 –0.574
113 Ed function Er–Er1 TP –0.714 –0.633
114 Eq function Er/Er1 TP –0.751 –0.668
115 Eavd function Erav–Er1av; Erav is Er per number of bonds TP –0.654 –0.621
116 Eavq function Erav/Er1av TP –0.657 –0.620
117 Cd function Cr–Cr1; Cr is the first order Randi} index for RCON TP –0.726 –0.645
118 Cq function Cr/Cr1 TP –0.760 –0.681
119 Cavd function Crav–Cr1av; Crav is Cr per number of bonds TP –0.654 –0.621
120 Cavq function Crav/Cr1av TP –0.657 –0.620
124 Err1av Err1 per number of bonds; Err1 is the first order extended Wiener
index for the whole molecule
TP –0.754 –0.650
125 wNS-tr function (wNS–0.400)
2 CO/EL/HB –0.654 –0.592
126 Er1 first order Wiener index for CR1/CMe2 TP 0.609 0.519
(a)Ordinal number as in the complete list with 126 molecular descriptors. (b)Molecular descriptors that have absolute correlation coefficients
greater than 0.600 with one or two pMICs. Molecular descriptors generated previously14 are marked with asterisk (*). Descriptors used in the final
PLS models are typed bold. (c)Simple or composite nature of molecular descriptors: compositional (CM), steric (ST), electronic (EL), topological
(TP), hydrogen bonding (HB) and hydrophobic (HP) character. (d)Correlation coefficients with pMIC(HN891) and pMIC(SH5014).
and external validation, the models can be considered
comparable to the analogous computed models14 and
therefore, are applicable in QSAR studies.
Descriptors with positive contribution to the increase
in biological activity (meaning increase of drug efflux rate,
i.e., decrease in pMIC values) are those having negative
regression coefficients. The major contributors to the ac-
tivity are Dav, Vav and Wsd. Nar1, Dav, Z, L and Wsd posi-
tively affect the activity increase. Concluding, larger hy-
drophobic or polar domains as well as low average elec-
tron content (characteristic for hydrophobic and even am-
phiphilic species) and pronounced differences in size/bran-
ching of fragments R and R1 (this is in favor of penicil-
lins where R1 is very small) are the main determinants of
properties of good pump substrates (bad drugs).
HCA Analysis
Descriptors used in the PLS modeling are two extensive
properties (Nar1, L) related to molecular/fragment size,
and five intensive descriptors (Dav, Vav, wDA, Z, Wsd) ac-
counting for overall shape, electronic features, HB po-
tency and lipophilic character of molecules/fragments.
Absolute correlation coefficients for descriptor intercor-
relations vary in the range 0.38–0.95. HCA analysis (Fig-
ure 6a) exhibits two main clusters defined by similarity
indices 0.61 and 0.63. The clusters take into account po-
sitive (Wsd, Dav) and negative (Nar1, L, Z, Vav, wDA) cor-
relations with pMICs. The descriptors are grouped in ac-
cordance with their nature: predominantly structural (Wsd,
Dav), electronic (Z, Vav) and complex (Nar1, L) descrip-
tors, and an isolated HB descriptor (wDA). However, when
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TABLE II. Biological activities and molecular descriptors used in PLS models
No. pMIC(HN891) pMIC(SH5014) Nar1 Dav Vav wDA Z L 10
6 Wsd
1 2.310 2.607 3 4.1 3.04 0.207 0.154 12 2621
2 2.629 2.930 3 4.8 3.30 0.241 0.462 13 2304
3 4.019 4.621 3 4.6 3.05 0.261 0.000 12 480
4 4.695 4.996 6 3.7 3.37 0.269 1.333 15 681
5 4.427 5.029 6 3.5 3.41 0.286 1.333 15 681
6 4.717 4.717 8 4.0 3.20 0.214 0.476 16 9
7 4.073 4.675 3 4.3 3.29 0.308 0.400 12 1616
8 4.112 4.714 3 4.5 3.40 0.333 0.727 12 2025
9 3.921 3.921 11 4.0 3.42 0.306 1.127 19 404
10 6.318 6.637 9 2.9 3.52 0.361 1.295 18 202
11 5.959 6.579 6 3.0 3.48 0.333 1.500 17 92
12 6.364 6.665 12 2.8 3.65 0.389 1.518 20 4
13 5.674 5.975 9 3.0 3.48 0.367 1.350 17 751
14 5.055 5.357 9 4.1 3.62 0.414 1.417 17 0
15 4.652 4.652 3 4.0 3.05 0.375 0.625 13 85
16 4.414 4.414 6 3.1 3.21 0.357 1.475 17 1369
Figure 6. HCA dendograms for seven selected molecular descriptors that characterize MDR efflux activity of strain HN891. Similarity indi-
ces and the sign of descriptor-activity linear correlation coefficients are marked in the dendogram. a) Original descriptors. b) Descriptors
with always positive correlation coefficients with biological activities.
–Wsd and –Dav are used, to eliminate the differences in
signs of the correlation coefficients, the new clustering
pattern is different (Figure 6b). It is based on descriptor
intercorrelations and absolute activity-descriptor correla-
tions rather than on the nature of the descriptors.
The dendogram of b-lactams (Figure 7) has two main
clusters defined by similarity indices 0.56 and 0.60,
which exhibit structural differences between penicillins
and cephalosporins (with the exception of 6). Sub-clus-
ters I, II, III (A and B) and IV, defined by similarity in-
dices 0.69–0.78, are related to the respective biological
activity values. The compounds have been classified pre-
viously as good (G), moderately good (M) and poor (P)
substrates of the AcrAB-TolC pump (as marked in Fig-
ure 7), based on exploratory analysis for pMICs data.14
However, the new exploratory analysis with a priori de-
scriptors shows a more complex situation. The sub-clus-
ter I contains the best substrates (G and some M), while
moderately good substrates (M) are divided among II,
IIIA and IV. Poor substrates (P) are in the sub-cluster
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TABLE III. Comparison of the HN891 and SH5014 PLS models with regression statistics
Parameters HN891 model SH5014 model
Regression model
Training set / External validation set(a) 16 / 0 16 / 0
PCs (%Var)(b) 4 (85.9 %) 4 (84.4 %)
SEV(c) 0.461 0.491
SEC(c) 0.294 0.294
Q, Q2(d) 0.913, 0.829 0.906, 0.816
R, R2(d) 0.976, 0.952 0.977, 0.955
R.e. (10.00 %)(e) 3 1
Max. R.e.(e) 14.4 % 11.2 %


















Training set / External validation set(a) 13 / 3 13 / 3





ev 0.855, 0.703 0.834, 0.661
Rev, R
2
ev 0.972, 0.945 0.978, 0.956






(a)Number of b-lactams in the training and external validation sets.
(b)Number of used principal components and the corresponding % variance of the X data matrix.
(c)Standard deviations of the PLS model: SEV – standard error of leave-one-out crossvalidation, SEC – standard error of prediction (calibration).
(d)Correlation coefficients of the PLS model: Q – Linear correlation coefficient of leave-one-out crossvalidation, Q2 – correlation coefficient of
leave-one-out crossvalidation, R – linear correlation coefficient of calibration, R2 – correlation coefficient of calibration.
(e)Relative errors: R.e.  10.00 % – number of b-lactams with relative error  10.00 %, Max. R.e. – maximum relative error, Mean R.e. – mean rel-
ative error (calculated from absolute values of relative errors).
(f)Regression vector components for descriptors in autoscaled form and descriptor-activity linear correlation coefficients (in brackets).
(g)Common parameters for the training set in external validation: SEVev – standard error of leave-one-out crossvalidation, SECev – standard error
of prediction (calibration), Qev – linear correlation coefficient of validation, Q
2
ev – correlation coefficient of validation, Rev – linear correlation co-
efficient of calibration, R2ev – correlation coefficient of calibration.
(h)Predicted biological activities and relative errors (in brackets) for b-lactams from the external validation set.
IIIB. From the structural point of view, b-lactams with
the shortest and very short side-chains (-NH-CO-R,
-C2Me2- and –CH2-R1) belong to I and II, respectively.
This is visible from the respective low values of L and
Nar1, and the high values of Wsd (Table II). The sub-clus-
ter IIIB consists of the molecules richest in heteroatoms
(N, S, O as noted before14), described by high Vav, wDA, Z
and L, and low Dav. The largest molecules and those with
the longest side chains belong to this sub-cluster. Molecules
in IIIA have similar characteristics, with the exception
of greater values of Dav. b-Lactams in IV are of moder-
ate size and are characterized by intermediate values of
most descriptors (Nar1, Dav, L, Wsd, wDA, Vav). In general,
the liphophilic or amphiphilic character of b-lactams is
related to better efflux (lower pMIC), as has been repor-
ted.19 This is also visible in the clustering pattern of the
HCA dendogram.
PCA Analysis
Table IV contains cumulative variances for PC1-PC7
from PCA analyses using data sets A (Table II), B and C
(Table I, descriptors with absolute correlation coefficients
> 0.600 with pMIC(HN891) and pMIC(SH5014), respe-
ctively).
The loadings plots in Figure 8 take into account
PC1-PC2 from PCA applied to the data set A (Table II)
that was used for the PLS models (Table III) and HCA
(Figure 6). PC1 separates descriptors in the same way as
in HCA (Figure 6a), i.e., depending on the sign of their
correlation coefficients with pMICs. The clustering in the
PC1-PC2 plot (Figure 8a) according to the nature of des-
criptors (structural, electronic, HB and complex) follows
practically the same pattern as in HCA. PC2 discrimina-
tes descriptors that have a steric and/or hydrophobic na-
ture (Dav, L and Nar1 at negative PC2) from electronic
(Vav and Z where PC2 ranges from 0.2 to 0.4) and topo-
logical/HB descriptors (Wsd and wDA at highly positive
PC2).
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Figure 7. HCA dendogram for seven selected molecular descrip-
tors that characterize MDR efflux activity of strain HN891. b-Lac-
tams are labeled as good (G), moderately good (M) and poor (P)
MDR substrates according to the previous chemometric study.14
Ranges of experimental pMICs for sub-clusters and similarity indi-
ces are given also.
Figure 8. PCA plots with the first two principal components: a) loadings plot and b) scores plot. PCA was based on seven selected molec-
ular descriptors (data set A) that characterize MDR efflux activity of strain HN891. b-Lactams are marked in different ways to distinguish
charged species (anion: –, dianion – –, zwitterion + –, anion-zwiterion – + –), b-lactams with different contents of hydrophobic atoms
(vertical dashed line at 49 % content), biological activity classes (G, M, P) and species with different ring-containing side chains (gray: R
and R1; gray dots: R1; gray vertical lines: no rings; white: R).
The PC1-PC2 scores plot is in Figure 8b. The clus-
tering pattern in this plot is very similar to that in the HCA
dendogram in Figure 7, with the exception of groups
IIIA and IIIB, which cannot be identified in the scores
plot. PC1 discriminates penicillins from cephalosporins,
which is the major determinant of clusters with good (G),
moderately good (M) and poor (P) substrates of AcrAB-
-TolC pump. The limit of 49 % for values of a lipophilic
descriptors (hydrophobic surface area fraction Sf), arbi-
trarily positioned in the plot, discriminates more hydro-
phobic (at negative PC1) from more polar (at positive
PC1) b-lactams. The number and type of charged groups
distinguish anions (–), dianions (– –), zwitterion (+ –),
and anion-zwitterions (– + –) that tend to cluster. This
means that the two properties, hydrophobicity and charge,
affect the behavior of b-lactams in interaction with
strains of S. typhimurium, as discussed previously.14 b-
-Lactams in the PC1-PC2 plot are distinguished accord-
ing to the number and position of rings in fragments R
and R1: species without rings (4, 15, 16 in the central part
of the plot), b-lactams with rings only in R (1–3, 5, 7, 8,
11 in the left and central part), an anion with ring only in
R1 (13 in the central part), and species with rings in R
and R1 (6, 9, 10, 12, 14 in the right part and bottom of
the plot). Consequently, the number and position of ring
structures in the side chains also affect b-lactam behav-
ior. Descriptors with significant or exclusive structural/
hydrophobic character in the PC1-PC2 loadings plot
(Figure 8a) determine the behavior of b-lactams in the
same part of the PC1-PC2 scores plot (Figure 8b): all pe-
nicillins and cephalosporin 6 (a well-defined cluster in
Figure 7). Descriptors with predominant electronic and
HB nature are the major determinants of the behavior of
most cephalosporins, especially of poor substrates (10–13)
and 14 that are the richest b-lactams in nitrogen and sul-
fur atoms (potential HB donor/acceptor groups). In gen-
eral, lower values of PC1 are related to more active
b-lactams with large R and small R1 substituents in the
side chains (large Wsd, small Nar1 and L values), mole-
cules that are more hydrophobic and possess well-de-
fined large hydrophobic and polar domains (large Dav
values). Higher PC1 is related to larger and more polar
molecules rich in heteroatoms and HB groups. Hence,
PC1 can be considered as a general PC built by all de-
scriptors related to pMIC(HN891) and pMIC(SH5014) with
correlation coefficients 0.847 and 0.787, respectively. PC1
describes overall molecular amphiphilicity, which de-
creases with hydrophobic and increases with polar char-
acter of b-lactams. Consequently, the increase of bacte-
rial MDR efflux power is related to the decrease in PC1.
PC1 contains about 2/3 and PC2 significantly
smaller percentage (only 11 %) of the total variance. Si-
milar trends are observed in other related PCA analyses
(see Table IV), which suggests that the seven selected
descriptors (data set A) are good representations of the
data sets B and C. Descriptors Dav and wDA make the high-
est contribution to PC2 (Figure 8 top), and thus are best
correlated with this PC (correlation coefficient is 0.46 and
0.50, respectively). The scores plot (Figure 8b) shows that
PC2 discriminates b-lactams in a rather complex way.
The largest molecules as well as smaller ones with pro-
nounced hydrophobic (1), amphiphilic (4, 5, 15) and po-
lar character (10–12) are placed in the middle of the plot,
i.e. around PC2 = 0. In general, molecular size and hy-
drophobicity increase and polar character and HB po-
tency decrease with PC2, placing 3, 6 and 9 in the bot-
tom part of the plot. The opposite is observed for increas-
ing PC2, due to which 2, 7, 8, 13, 14 and 16 are posi-
tioned in the top part of the plot. Molecular topology
also varies along PC2. More branched b-lactams are at
high positive PC2, and molecules with more compact R
and R1 are placed at negative PC2. Since both Wsd and
wDA are positively correlated with PC2, the chemical
meaning of this PC is related to the topological distribu-
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TABLE IV. Basic PCA statistics(a) related to the dimensionality(b) of pMIC-related data sets
Data sets
A: 7 descriptors (HN891/SH5014)(c) B: 66 descriptors (HN891)(d) C: 44 descriptors (SH5014)(e)
PC % CVar. % CVar. % CVar.
1 68.36 69.25 67.67
2 78.94 79.74 78.66
3 87.81 85.66 85.48
4 95.07 90.35 90.38
5 98.05 93.53 93.46
6 99.68 95.66 95.62
7 100.00 96.80 97.03
(a)Cumulative variance (% CVar.) described by each principal component (PC). (b)Principal components that probably determine the maximum
dimensionality of the data are typed italics and those with significant fraction of the total variance are typed bold. (c)Data set A: seven descriptors
used in PLS modeling for both strains (Table II). (d)Data set B: descriptors with absolute correlation coefficients > 0.600 with pMIC(HN891).
(e)Data set C: descriptors with absolute correlation coefficients > 0.600 with pMIC(SH5014).
tion of HB groups, i.e. HB potency depends on the size
and shape of R and R1.
PC3 contains 9 % of the original information in this
PCA analysis, similar to the other related PCA analyses
(Table IV). It seems that this PC maintains some cluster-
ing patterns of b-lactams with respect to 5- and 6-mem-
bered rings in the side chains R and R1 (scores plots not
shown). PC4 contains 7 % total variance, whilst in the
other related PCA analyses this contribution is 4–5 %
(Table IV). This PC is responsible for certain clustering
patterns of b-lactams with respect to molecular topology
and hydrophobic character (scores plots not shown).
New Type of Molecular Descriptors: Amphiphilic
Descriptors?
PLS models (Table III) and PCA analyses (Table IV) use
four principal components. PC3 and PC4 in the regres-
sion models and PCA for the data set A have mainly
originated from descriptors Dav and Vav. These descrip-
tors, considered as structural/hydrophobic and electronic,
respectively (Figure 6), seem to describe overall molec-
ular amphiphilicity. This is important to note for b-lac-
tams, which are, due to their basic molecular structure,
essentially amphiphilic. This fact can be an important
determinant for b-lactam interactions with proteins and
membranes.
Vav is low for more hydrophobic compounds (ben-
zene: 2.50), moderate for amphiphilic (phenol: 2.77),
and high for more polar substances (trinitrophenol:
4.42). The Vav increase is also related to high contents of
unsaturated bonds and low contents of hydrogen atoms,
so it is best to compare compounds within the same
class. Vav values for the b-lactams in this work vary over
a relatively narrow range, 3.04–3.65 or 20 %. PLS equa-
tions (Table III) clearly demonstrate the decrease in bio-
logical activity with the increase in Vav.
Dav includes hydrophobic, polar, topological and
size/shape characteristics of the b-lactam side chains.
Figure 4 illustrates extreme values of this descriptor,
within the maximum for 2 (4.8) and the minimum for 12
(2.8). 2 is a smaller species with 6 domains along the
R-R1 path of 13 atoms, and 12 is a larger species with 13
domains and 20 atoms along the path. 2 has larger and
better defined domains, whilst 12 has pronounced mo-
saic character. Hence, the polar and hydrophobic groups
form almost two continuous domains that facilitate the
molecular recognition between b-lactams and AcrB re-
ceptors. The average size of domains in 2 (4.8) corre-
sponds to 4- or 5-membered rings, while in 12 this num-
ber is rather small (2.8) to form structural units that would
interact with amino-acid residues of AcrAB-TolC. Dav is
elevated for molecules with large domains or with
highly pronounced hydrophobic or polar character. The
other extreme case is Dav = 1 for molecules with many
monoatomic domains (the highest possible mosaicity).
Amphiphilic molecules thus may have intermediate values
of Dav, like the b-lactams in this work (2.8–4.8) and
some amino-acids (leucine: 2.50; phenyalanine: 4.00; tryp-
tophane: 4.00). The existence of well-defined lipophilic
and hydrophilic domains in b-lactams and other antibiot-
ics, as amphiphilic compounds, has been pointed out by
van Bambeke et al.24
To test the amphiphilic character of Vav and Dav, the
respective linear correlation coefficients with 12 lipophilic
descriptors from the earlier work14 and 7 electronic/HB
descriptors (5 in PLS modeling and third-order polariza-
bility, also previously calculated,14 and wDA), were eval-
uated. Absolute coefficients for Vav vary over a large range
with lipophilic (0.107–0.607) and electronic/HB descrip-
tors (0.154–0.800). A similar trend is observed for Dav
with respect to lipophilic (0.099–0.727) and electronic/
HB descriptors (0.045–0.782). This indicates the amphi-
philic character of Vav and Dav.
Hansch et al. have shown recently52 that the number
of valence electrons, which is directly related to molecu-
lar polarizability, is an important molecular descriptor in
QSAR. This supports the use of the intensive descriptor
Vav for QSAR. Besides classical descriptor types, amphi-
philic descriptors could be considered as a new class of
descriptors. b-Lactam amphiphilicity seems to be impor-
tant in processes like drug-membrane and drug-AcrB in-
teractions (Figure 2), drug-intestinal transporter44,45 and
general drug-protein interactions (mainly of electrostatic
and hydrophobic natures).43,53 Membranes and proteins
involved in b-lactam efflux in Gram-negative bacteria
(Figure 2) are generally hydrophilic microinterfaces. The
central cavity of AcrB possesses receptor sites able to
accommodate a large variety of structurally diverse am-
phiphilic drugs. b-Lactams establish diverse intermole-
cular interactions with the receptors, as has been seen
during the modeling of AcrB complexes with 1–1640 and
from crystal the structure of AcrB-1.34
Intramolecular Interactions between b-Lactam Side
Chains
Several descriptors in Table II encode information on in-
teractions between the side chains R and R1: wDA (HB
donor/acceptor balance between R and R1), L and Z
(chemical balance between R and R1), and Nar1, Dav and
Vav (size, shape and electronic features). These descrip-
tors indicate that longer and more flexible side chains with
elevated numbers of polar/HB or hydrophobic groups can
adopt conformations which enhance intramolecular inter-
actions. The descriptor Wsd positively contributes to the
activity increase. W and W1 are included in its definition
(Table I) as Wsd = (Wn – Wn1)
2, where Wn and Wn1 are W
and W1 normalized by the cube of the number of corre-
sponding non-H atoms, respectively. b-Lactams with pro-
nounced size/shape differences between the side chains,
mainly penicillins, have elevated Wsd (large rings: 1, 2,
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7, 8; long chain: 16). b-Lactams with minimum Wsd are
cephalosporins with similar rings in R and R1 (6, 12, 14).
The b-lactam ring and peptide bond form two dis-
tinctive regions: a large hydrophobic domain and three
polar domains that make a continuous 3D polar/HB re-
gion. Cronin et al.47 have noted that intramolecular HB
descriptors are important for biological activity of a va-
riety of antibacterials. For example, intramolecular hy-
drogen bonds participate in stabilization of erythromycin
and rifampicin 3D structure.38 Computed 3D structures
of the 16 b-lactams14 have shown various interactions be-
tween hydrophobic, polar, charged and HB groups in the
side chains. These interactions stabilize compact, U-shaped
or bent conformers. Since linear cylinder-like shapes
are preferred for drug interactions with the pump recep-
tors and channels,38 compact and globular conformers of
b-lactams are bad pump substrates. Complex substitu-
ents in b-lactams may contain small hydrophobic/polar
domains, which makes these molecules unsuitable for
interactions with all AcrAB-TolC receptors. Predomi-
nantly polar molecules do not accumulate at the inner
membrane (Figure 1) and thus, are harder to be ex-
creted.18 The presence of large R1 and polar R, and the
pronounced overall polar and mosaic character of a b-
-lactam do not favor drug-receptor interactions. These
intermolecular interactions, unlike in most QSAR stud-
ies where strong interactions result in stable drug-recep-
tor complex, may be considered sufficiently strong to at-
tract a drug molecule but weak enough to enable further
drug movement from one receptor to another along the
efflux pathway. Bad b-lactam substrates can be strongly
bound to the AcrB receptors, which then disables effi-
cient efflux of such drugs.
The interaction between the two side chains can be
direct (contact) or indirect (mediated by the central
ring), affecting the efflux rates pMIC. The application of
chemometrics in this work has indicated the possibility
of such interactions. This may favor the use of a priori
descriptors to describe complex phenomena such as
MDR. Olah et al.54 have recently shown the usefulness
of 1D and 2D descriptors as biologically relevant in
more than 1600 QSAR-PLS models, which just may
confirm that a priori descriptors, due to their nature, can
be useful in QSAR studies.
CONCLUSION
The chemometric methodologies applied in this work
lead to the following conclusions:
1) Advantages of the a priori approach are chemical
interpretation and understanding of descriptors and
drugs (b-lactams), with easy generation of the de-
scriptors and acceptable PLS statistics.
2) Classification of b-lactams as good, moderately
good and poor substrates of the AcrAB-TolC pump
is confirmed, although the clustering pattern seems
to be more complex.
3) Some descriptors are shown to have an amphiphilic
nature, which is rare in QSAR studies.
4) Intramolecular interactions between the side chains
affect physico-chemical (hydrophobicity, amphiphi-
licity and hydrogen bonding potency) and biological
properties of b-lactams.
5) The a priori approach in this work represents an in-
teresting example of how much a relatively complex
phenomena such as bacterial multidrug resistance can
be treated in a rather simply way.
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SAETAK
A priori deskriptori u QSAR: slu~aj vi{estruke otpornosti Gram-negativnih bakterija
prema b-laktamima
Rudolf Kiralj i Márcia M. C. Ferreira
Izra~unato je vi{e od stotine globalnih i lokalnih molekulnih opisiva~a a priori za steri~ka, topolo{ka, elek-
tronska i hidrofobna svojstva, kemijski sastav i svojstva vodikovih veza 16 b-laktama. Dva su regresijska mo-
dela izgra|ena metodom parcijalnih najmanjih kvadrata i ispitana unakrsnom provjerom. A priori modeli (Q2 >
0,80, R2 > 0,95, SEV < 0,50) su usporedivi s prethodno dobivenim ra~unskim modelima. Raspravljano je i o
unutarmolekulnim djelovanjima u b-laktamima i me|umolekulnim djelovanjima b-laktam-receptor u smislu mo-
lekulskih opisiva~a.
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